NIH supports exploratory and developmental research addressing critical needs in Down syndrome to improve health and quality of life; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: October 15, 2026 (Application) | June 15, 2027 (Application) | June 15, 2028 (Application)
Funding Amounts: Up to $275,000 in direct costs over 2 years, with no more than $200,000 in any year
Summary: Supports novel exploratory and developmental Down syndrome research with potential to improve health and quality of life.
Key Information: Clinical trials and foreign subawards/subcontracts are not allowed.
The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project supports new exploratory and developmental research addressing critical gaps in Down syndrome research. This R21 opportunity encourages high-risk work that could establish the feasibility of a new scientific direction, test a new experimental system, or apply an existing methodology in an innovative way.
Projects should break new ground or extend previous discoveries toward new directions or applications, potentially producing new techniques, agents, models, or tools for biomedical, behavioral, or clinical research. Long-term projects and incremental studies in well-established areas are not appropriate. Extensive preliminary information is not expected, and preliminary data are not required. Human-subjects research is permitted when it does not constitute a clinical trial.